Brief: Sensei Biotherapeutics Appoints Patrick Gallagher As Chief Business Officer
01/06/2022 12:41
June 1 (Reuters) - Sensei Biotherapeutics Inc SNSE.O :
* SENSEI BIOTHERAPEUTICS APPOINTS PATRICK GALLAGHER, MBA,
MPH, AS
CHIEF BUSINESS OFFICER
Source text for Eikon: ID:nGNX5Pq9cd
Further company coverage: SNSE.O
Recent news on Faeth Therapeutics
See all newsU.S. STOCKS ON THE MOVE - Nvidia, Gold miners, Nike
U.S. STOCKS ON THE MOVE - Sunrun, JetBlue Airways, Dell Technologies
Faeth Therapeutics rises after FDA grants fast-track status for cancer drug
Brief: Faeth Therapeutics Announces FDA Grant Of Fast Track Designation For Piktor Plus Paclitaxel In Biomarker-Selected Advanced Endometrial Cancer
Brief: Faeth Therapeutics Strengthens Executive Team With Senior Leadership Appointments